Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials

Patients older than 75 years of age are usually excluded from metastatic colorectal cancer studies based on a combination chemotherapy containing oxaliplatin. Our group conducted three phase II trials in elderly patients in recent years. A post-hoc subgroup analysis of 67 patients aged at least 75 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosati, Gerardo, Cordio, Stefano, Reggiardo, Giorgio, Aprile, Giuseppe, Butera, Alfredo, Avallone, Antonio, Tucci, Aniello, Novello, Giuseppe, Blanco, Giuseppina, Caputo, Giuseppe, Bilancia, Domenico, Bordonaro, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521155/
https://www.ncbi.nlm.nih.gov/pubmed/31022922
http://dx.doi.org/10.3390/cancers11040578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521155/
https://www.ncbi.nlm.nih.gov/pubmed/31022922
http://dx.doi.org/10.3390/cancers11040578

Ejemplares similares